Pulmonary arterial hypertension (PAH), a common complication of systemic sclerosis, carries a very severe prognosis and is one of the leading causes of death in patients who suffer from it. Indeed, ...

Pulmonary arterial hypertension (PAH) is a severe and life-threatening complication often associated with scleroderma, also known as systemic sclerosis (SSc). Scleroderma is a chronic autoimmune ...

Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States Systemic sclerosis is an autoimmune disorder of the ...

CLEVELAND — Every patient with systemic sclerosis should be screened for pulmonary arterial hypertension every year, as early recognition, referral and aggressive treatment are necessary to improve ...

Isolated pulmonary hypertension (PHT) is now the most frequent cause of disease-related death in limited cutaneous scleroderma, the commonest disease variant of this disabling connective tissue ...

A 68-year–old woman had been experiencing Raynaud symptom, palpitation of the heart, and short breath in walking stairs or slopes for 7 years. Recently, these symptoms had rapidly become worse. She ...

Pulmonary hypertension (PAH) is a feared complication of scleroderma and a leading cause of mortality in this disease. In this study, Shah and colleagues evaluated the factors that could predict PAH ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO — Risks for pulmonary hypertension and pulmonary arterial hypertension among patients with scleroderma ...

Screening for a sometimes fatal condition among patients with a rare autoimmune disease could soon - thanks to a computer algorithm - become even more accurate. Researchers at Michigan Medicine found ...

The following is a summary of “Sildenafil Versus Placebo for Early Pulmonary Vascular Disease in Scleroderma (SEPVADIS): protocol for a randomized controlled trial,” published in the April 2024 issue ...